1. Abdel-Ghany, M., El-Sabae, A. K., and Shalloway, D., 1993, Aluminum-induced nonenzymic phospho-incorporation into human tau and other proteins, J. Biol. Chem.
268:11976–11981.
2. Adams, J. D., Jr., Kaidman, L. K., Odunze, I. N., Shen, H. C., and Miller, C. A., 1991, Alzheimer’s and Parkinson’s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E, Mol. Chem. Neuropathol.
14:213–226.
3. Agnoli, A., Fabbrini, G., Fioravanti, M., and Marucci, N., 1992, CBF and cognitive evaluation of Alzheimer type patients before and after IMAO-B treatment: A pilot study, Eur. Neuropsychopharmacol.
2:31–35.
4. Ahlskog, J. E., Uitti, R. J., Low, P. A., Tyce, G. M., Nickander, K. K., Petersen, R. C., and Kokmen, E., 1995, No evidence for systemic oxidant stress in Parkinson’s or Alzheimer’s disease, Mov. Dis.
10:566–573.
5. Alberts, M. J., Ioannu, P., Deucher, R., Gilbert, J., Lee, J., Middleton, L., Roses, A. D., 1992, Isolation of a cytochrome oxidase gene overexpressed secretase cleavage of amyloid precursor protein, J. Neurochem.
64:307–315.